| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |